Latest On Solid Biosciences Inc (SLDB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 10:26 EST | News | Solid Biosciences reports Q1 results | N/A |  |
| 2023-03-24 00:27 EST | News | Solid Biosciences reports Q4 results | N/A | |
| 2023-01-11 14:23 EST | News | Solid Biosciences, Phlox team up to develop precision drugs for heart diseases | N/A | |
| 2023-01-09 20:25 EST | News | Kevin Tan is the new finance chief at Solid Biosciences | N/A | |
| 2022-11-10 23:10 EST | News | Solid Biosciences reports Q3 results | N/A | |
| 2022-10-27 14:21 EST | News | Solid Biosciences announces 1-for-15 reverse stock split | N/A | |
| 2022-09-30 23:08 EST | News | Solid Biosciences to acquire gene therapy company AavantiBio | N/A | |
| 2022-09-30 23:08 EST | News | Solid Bio adds 14% as JPMorgan upgrades on AavantiBio buyout | N/A | |
| 2022-08-11 15:31 EST | News | Solid Biosciences reports Q2 results | N/A | |
| 2022-04-30 23:05 EST | News | Solid Biosciences Inc. (SLDB) CEO Ilan Ganot on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 18:52 EST | News | Warning: SLDB is at high risk of performing badly | N/A | |
| 2021-11-03 18:51 EST | News | Solid Biosciences EPS beats by $18.20, beats on revenue | N/A | |
| 2021-11-02 23:10 EST | News | Regenxbio-Solid Biosciences' PDC releases white paper for AAV gene therapy development | N/A | |
| 2021-10-09 09:35 EST | News | Solid Biosciences Investor Presentation - Slideshow | N/A | |
| 2021-09-29 23:16 EST | News | Solid Biosciences posts additional pulmonary function data from early-stage DMD trial | N/A | |
| 2021-09-23 11:54 EST | News | Solid Bio gains 11% on positive SGT-001 data after 1.5 years in Duchenne Muscular Dystrophy trial | N/A | |
| 2021-09-22 06:01 EST | News | Solid Biosciences surges ahead of presentation on Duchenne muscular dystrophy trial | N/A | |
| 2021-08-17 00:41 EST | News | Solid Biosciences EPS beats by $0.01, beats on revenue | N/A | |
| 2021-07-22 00:53 EST | News | LMNL, CLAR, FIXX and PETS among after-hours movers | N/A | |
| 2021-04-11 14:18 EST | News | Solid Biosciences: Future More Uncertain Than Solid | N/A | |
| 2021-03-29 17:47 EST | News | Suvretta Capital discloses 5.4% stake in Solid Biosciences; shares rise 6% post-market | N/A | |
| 2021-03-26 15:29 EST | News | Solid Biosciences (SLDB) Investor Presentation - Slideshow | N/A | |
| 2021-03-20 02:25 EST | News | Solid Biosciences prices $125M capital raise | N/A | |
| 2021-03-18 09:41 EST | Analyst Rating | The Analyst Target Price has increased from $9.92 to $11.17. | Buy | |
| 2021-03-18 05:27 EST | News | Solid Biosciences enters $85M capital raise | N/A | |
| 2021-03-17 21:50 EST | Analyst Rating | The Analyst Target Price has increased from $7.75 to $9.92. | Buy | |
| 2021-03-17 08:13 EST | News | Solid Biosciences reports mid-stage data in Duchenne muscular dystrophy trial | N/A | |
| 2021-03-17 08:12 EST | News | Biogen expected to receive FDA nod for Alzheimer’s therapy and Solid Bioscience upgraded in today’s analyst action | N/A | |
| 2021-03-17 08:11 EST | News | Solid Biosciences upgraded at SVB Leerink on DMD trial data | N/A | |
| 2021-03-16 22:02 EST | Earnings Estimate | An EPS average of -$0.96 is estimated for the 2022 year. | Sell | |
| 2021-03-16 22:02 EST | Earnings Estimate | An EPS average of -$0.30 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-10 12:19 EST | Analyst Rating | The Analyst Target Price has increased from $6.7 to $7.75. | Neutral | |
| 2021-01-11 22:54 EST | News | Solid Bio sinks 13% after Sarepta data misses goal | N/A | |
| 2021-01-11 04:33 EST | Analyst Rating | The Analyst Target Price has increased from $5.7 to $6.7. | Neutral | |
| 2021-01-08 07:21 EST | News | Soild Bio sinks 13% after Sarepta data misses goal | N/A | |
| 2021-01-04 04:54 EST | Analyst Rating | The Analyst Target Price has increased from $4.7 to $5.7. | Neutral | |
| 2020-12-11 11:44 EST | News | Solid Biosciences launches $90M private placement, shares up 23% premarket. | N/A | |
| 2020-11-26 21:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 00:28 EST | News | Solid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial Data | N/A | |
| 2020-11-10 05:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 05:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 14:19 EST | News | Solid Biosciences' (SLDB) CEO Ilan Ganot on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 08:51 EST | Earnings Estimate | An EPS average of -$0.23 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-05 15:04 EST | News | Solid Biosciences EPS misses by $0.10 | N/A | |
| 2020-10-24 08:47 EST | News | Ultragenyx, Solid Biosciences in pact for Duchenne gene therapies | N/A | |
| 2020-10-03 09:57 EST | Analyst Rating | The Analyst Target Price has increased from $3 to $4.7. | Neutral | |
| 2020-10-01 23:45 EST | News | FDA lifts hold on Solid Bio's Duchenne study; shares rocket 61% | N/A | |
| 2020-10-01 23:44 EST | News | Chardan raises Solid Biosciences price target 250% | N/A | |
About Solid Biosciences Inc (SLDB):
Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to derive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
General
- Name Solid Biosciences Inc
- Symbol SLDB
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 121
- Fiscal Year EndDecember
- IPO Date2018-01-26
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.solidbio.com
View More
Valuation
- Price/Book (Most Recent Quarter) 4.29
View More
Financials
- Most Recent Quarter 2020-09-30
- Current Year EPS Estimate -$1.55
- Next Year EPS Estimate -$1.31
- Next Quarter EPS Estimate -$0.26
- Return on Assets -71%
- Return on Equity -151%
- Earnings Per Share -$2.80
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 515.04 million
- EBITDA -96527000
- Analyst Target Price $11.17
- Book Value Per Share $1.56
View More
Share Statistics
- Shares Outstanding 85.13 million
- Shares Float 1.78 million
- % Held by Insiders 3232%
- % Held by Institutions 67.38%
- Shares Short 2.75 million
- Shares Short Prior Month 2.22 million
- Short Ratio 2.02
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.17
- 52 Week High $11.58
- 52 Week Low $1.93
- 50 Day Moving Average 8.14
- 200 Day Moving Average 5.2
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Solid Biosciences Inc (SLDB) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Solid Biosciences Inc (SLDB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | -$0.31 | -$0.34 | 8.82% | |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.44 | -$0.37 | -20.55% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.39 | -$0.50 | 21.47% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.52 | -$0.53 | 3.34% |
| 2019-12-31 | 2020-03-12 | $N/A | -$0.65 | -$0.60 | -8.24% |
| 2019-09-30 | 2019-11-12 | $N/A | -$0.67 | -$0.67 | -0.4% |
| 2019-06-30 | 2019-08-14 | $N/A | -$0.76 | -$0.77 | 1.66% |
| 2019-03-31 | 2019-05-13 | $N/A | -$0.85 | -$0.63 | -35.22% |
| 2018-12-31 | 2019-03-13 | $N/A | -$0.64 | -$0.61 | -5.51% |
| 2018-09-30 | 2018-11-13 | $N/A | -$0.55 | -$0.56 | 1.49% |
| 2018-06-30 | 2018-08-10 | $N/A | -$0.52 | -$0.51 | -2.04% |
| 2018-03-31 | 2018-05-10 | $N/A | -$0.54 | -$0.41 | -30.94% |
| 2017-12-31 | 2018-03-29 | $N/A | -$0.89 | -$0.59 | -51.7% |
Solid Biosciences Inc (SLDB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Solid Biosciences Inc (SLDB) Chart:
Solid Biosciences Inc (SLDB) News:
Below you will find a list of latest news for Solid Biosciences Inc (SLDB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Solid Biosciences Inc (SLDB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 674.86 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 362.63 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 176.11 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | CALL | 0 | 0 | 130.76 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.63 | CALL | 0 | 1 | 150.6 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0.85 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0.64 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.25 | PUT | 0 | 1 | 236.67 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.8 | PUT | 0 | 3 | 97.36 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 1.6 | PUT | 0 | 5 | 130.26 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 205.16 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 255.15 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 0 | PUT | 0 | 0 | 252.91 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 156.89 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 0 | PUT | 0 | 0 | 253.34 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 10.01 | CALL | 0 | 10 | 428.42 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 4.5 | CALL | 0 | 25 | 248.41 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 4.8 | CALL | 0 | 108 | 159.94 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 1.5 | CALL | 11 | 49 | 88.17 | FALSE | 1.5 | 0 |
| 2024-06-21 | 12.5 | 0.98 | CALL | 0 | 23 | 111.27 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 2.5 | CALL | 0 | 34 | 113.99 | FALSE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | CALL | 0 | 0 | 152.46 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 1.15 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.29 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.4 | PUT | 0 | 38 | 171.77 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.3 | PUT | 0 | 63 | 125.69 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 1.15 | PUT | 0 | 20 | 100.61 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 2.9 | PUT | 0 | 10 | 101.37 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 163.36 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 133.22 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 195.42 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | PUT | 0 | 0 | 171.85 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 209.12 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | CALL | 0 | 0 | 280.83 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 3.4 | CALL | 0 | 6 | 172.51 | TRUE | 0 | 0 |
| 2024-09-20 | 7.5 | 4.7 | CALL | 0 | 6 | 109.13 | TRUE | 0 | 0 |
| 2024-09-20 | 10 | 2.39 | CALL | 0 | 40 | 99.6 | FALSE | 0 | 0 |
| 2024-09-20 | 12.5 | 1.5 | CALL | 11 | 17 | 86.42 | FALSE | 1.5 | 0 |
| 2024-09-20 | 15 | 2.3 | CALL | 0 | 11 | 98.29 | FALSE | 0 | 0 |
| 2024-09-20 | 17.5 | 0.8 | CALL | 0 | 7 | 113.73 | FALSE | 0 | 0 |
| 2024-09-20 | 20 | 0.55 | CALL | 0 | 7 | 100.35 | FALSE | 0 | 0 |
| 2024-09-20 | 22.5 | 0.5 | CALL | 0 | 58 | 104.87 | FALSE | 0 | 0 |
| 2024-09-20 | 25 | 0.7 | CALL | 0 | 14 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 140.32 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 2.6 | PUT | 0 | 5 | 126.19 | FALSE | 0 | 0 |
| 2024-09-20 | 10 | 2.25 | PUT | 0 | 10 | 96.35 | TRUE | 0 | 0 |
| 2024-09-20 | 12.5 | 0 | PUT | 0 | 0 | 118.51 | TRUE | 0 | 0 |
| 2024-09-20 | 15 | 0 | PUT | 0 | 0 | 103.59 | TRUE | 0 | 0 |
| 2024-09-20 | 17.5 | 0 | PUT | 0 | 0 | 109.87 | TRUE | 0 | 0 |
| 2024-09-20 | 20 | 0 | PUT | 0 | 0 | 111.96 | TRUE | 0 | 0 |
| 2024-09-20 | 22.5 | 0 | PUT | 0 | 0 | 125.56 | TRUE | 0 | 0 |
| 2024-09-20 | 25 | 0 | PUT | 0 | 0 | 155.73 | TRUE | 0 | 0 |
Latest SLDB Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $0.6408 |
| Jun 13, 2022 7:59 PM EST | 28 | $0.651 |
| Jun 13, 2022 7:59 PM EST | 100 | $0.6485 |
| Jun 13, 2022 7:59 PM EST | 21 | $0.6516 |
| Jun 13, 2022 7:59 PM EST | 22 | $0.6624 |
Solid Biosciences Inc (SLDB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924320017156/0000899243-20-017156-index.htm |
| 2019-03-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1707502/000000000019004753/0000000000-19-004753-index.htm |
| 2019-09-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1707502/000000000019013134/0000000000-19-013134-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000087504519000009/0000875045-19-000009-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031200/0000899243-18-031200-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031202/0000899243-18-031202-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031204/0000899243-18-031204-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031205/0000899243-18-031205-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031207/0000899243-18-031207-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031208/0000899243-18-031208-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031211/0000899243-18-031211-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924318031228/0000899243-18-031228-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000269/0000899243-19-000269-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000739/0000899243-19-000739-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000742/0000899243-19-000742-index.htm |
| 2019-01-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000970/0000899243-19-000970-index.htm |
| 2019-01-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000971/0000899243-19-000971-index.htm |
| 2019-01-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000973/0000899243-19-000973-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001954/0000899243-19-001954-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001955/0000899243-19-001955-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001956/0000899243-19-001956-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001957/0000899243-19-001957-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001959/0000899243-19-001959-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001960/0000899243-19-001960-index.htm |
| 2019-02-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319002338/0000899243-19-002338-index.htm |
| 2019-02-01 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319002340/0000899243-19-002340-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319004375/0000899243-19-004375-index.htm |
| 2019-03-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319006464/0000899243-19-006464-index.htm |
| 2019-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319013080/0000899243-19-013080-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319017134/0000899243-19-017134-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319017135/0000899243-19-017135-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319017188/0000899243-19-017188-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924319020588/0000899243-19-020588-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924320017092/0000899243-20-017092-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924320017154/0000899243-20-017154-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000089924320017156/0000899243-20-017156-index.htm |
| 2019-08-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000093583619000407/0000935836-19-000407-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000093583620000135/0000935836-20-000135-index.htm |
| 2020-11-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000093583620000595/0000935836-20-000595-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000101297518001285/0001012975-18-001285-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000101297519000502/0001012975-19-000502-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000110465920021938/0001104659-20-021938-index.htm |
| 2019-05-03 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1707502/000114036119008386/0001140361-19-008386-index.htm |
| 2019-05-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1707502/000114036119008388/0001140361-19-008388-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1707502/000114036120009881/0001140361-20-009881-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1707502/000114036120009884/0001140361-20-009884-index.htm |
| 2020-05-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1707502/000114036120012241/0001140361-20-012241-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000114420419008169/0001144204-19-008169-index.htm |
| 2019-07-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1707502/000114420419036692/0001144204-19-036692-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519003979/0001193125-19-003979-index.htm |
| 2019-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519018968/0001193125-19-018968-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312519032113/0001193125-19-032113-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312519040820/0001193125-19-040820-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312519040941/0001193125-19-040941-index.htm |
| 2019-03-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312519065709/0001193125-19-065709-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519072676/0001193125-19-072676-index.htm |
| 2019-03-13 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1707502/000119312519072709/0001193125-19-072709-index.htm |
| 2019-03-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1707502/000119312519075824/0001193125-19-075824-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519145404/0001193125-19-145404-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519173665/0001193125-19-173665-index.htm |
| 2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519204157/0001193125-19-204157-index.htm |
| 2019-07-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1707502/000119312519207100/0001193125-19-207100-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519220535/0001193125-19-220535-index.htm |
| 2019-09-03 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1707502/000119312519235866/0001193125-19-235866-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1707502/000119312519266639/0001193125-19-266639-index.htm |
| 2019-10-23 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1707502/000119312519272564/0001193125-19-272564-index.htm |
| 2019-10-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1707502/000119312519272578/0001193125-19-272578-index.htm |
| 2019-10-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1707502/000119312519276191/0001193125-19-276191-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312519316730/0001193125-19-316730-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520004274/0001193125-20-004274-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312520038071/0001193125-20-038071-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1707502/000119312520038388/0001193125-20-038388-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520070917/0001193125-20-070917-index.htm |
| 2020-03-13 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1707502/000119312520073038/0001193125-20-073038-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520108669/0001193125-20-108669-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520135602/0001193125-20-135602-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520171845/0001193125-20-171845-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520198729/0001193125-20-198729-index.htm |
| 2020-08-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1707502/000119312520211250/0001193125-20-211250-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520260507/0001193125-20-260507-index.htm |
| 2020-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520274925/0001193125-20-274925-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520276085/0001193125-20-276085-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1707502/000119312520286209/0001193125-20-286209-index.htm |
| 2020-11-06 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1707502/000119312520287986/0001193125-20-287986-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037117/0001209191-19-037117-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037121/0001209191-19-037121-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037122/0001209191-19-037122-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037123/0001209191-19-037123-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037124/0001209191-19-037124-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037127/0001209191-19-037127-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119037130/0001209191-19-037130-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119041954/0001209191-19-041954-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043479/0001209191-19-043479-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043481/0001209191-19-043481-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043483/0001209191-19-043483-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043485/0001209191-19-043485-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043487/0001209191-19-043487-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043491/0001209191-19-043491-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919119045880/0001209191-19-045880-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120000997/0001209191-20-000997-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120005404/0001209191-20-005404-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120005408/0001209191-20-005408-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120005410/0001209191-20-005410-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120005412/0001209191-20-005412-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120005414/0001209191-20-005414-index.htm |
| 2020-02-12 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120008909/0001209191-20-008909-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120008912/0001209191-20-008912-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120009823/0001209191-20-009823-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018883/0001209191-20-018883-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018892/0001209191-20-018892-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018909/0001209191-20-018909-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018918/0001209191-20-018918-index.htm |
| 2020-04-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120024597/0001209191-20-024597-index.htm |
| 2020-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120024599/0001209191-20-024599-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037558/0001209191-20-037558-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037560/0001209191-20-037560-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037564/0001209191-20-037564-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037576/0001209191-20-037576-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037585/0001209191-20-037585-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037591/0001209191-20-037591-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037594/0001209191-20-037594-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037688/0001209191-20-037688-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037691/0001209191-20-037691-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037696/0001209191-20-037696-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037698/0001209191-20-037698-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm |
| 2020-09-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120050272/0001209191-20-050272-index.htm |
| 2020-10-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1707502/000120919120056343/0001209191-20-056343-index.htm |
| 2019-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1707502/000156459019007462/0001564590-19-007462-index.htm |
| 2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459019018869/0001564590-19-018869-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459019031964/0001564590-19-031964-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459019042546/0001564590-19-042546-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1707502/000156459020010247/0001564590-20-010247-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459020022357/0001564590-20-022357-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459020037207/0001564590-20-037207-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1707502/000156459020050874/0001564590-20-050874-index.htm |
| 2019-07-31 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1707502/000170750219000002/0001707502-19-000002-index.htm |
| 2020-10-26 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1707502/000170750220000001/0001707502-20-000001-index.htm |
| 2019-03-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1707502/999999999519000469/9999999995-19-000469-index.htm |
| 2019-10-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1707502/999999999519002396/9999999995-19-002396-index.htm |
Solid Biosciences Inc (SLDB) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Solid Biosciences Inc (SLDB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3232%Institutional Ownership: 6738%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-08 | Juan Andrey Zarur | Director | Sell | 8,000.00 | 10.00 | 80,039.20 | 10,189.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319013080/0000899243-19-013080-index.htm |
| 2019-07-25 | Ilan Ganot | CEO & President | Buy | 21,505.00 | 4.65 | 99,998.25 | 1,123,631.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043483/0001209191-19-043483-index.htm |
| 2020-07-28 | Ilan Ganot | CEO & President | Sell | 11,124.00 | 2.42 | 26,910.07 | 1,148,007.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm |
| 2020-07-27 | Ilan Ganot | CEO & President | Buy | 35,500.00 | 1,159,131.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043949/0001209191-20-043949-index.htm | ||
| 2019-07-25 | Carl Ashley Morris | Chief Scientific Officer | Buy | 21,505.00 | 4.65 | 99,998.25 | 133,050.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043485/0001209191-19-043485-index.htm |
| 2020-06-16 | LYNETTE HERSCHA | Chief Legal Officer | Buy | 75,000.00 | 150,000.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037688/0001209191-20-037688-index.htm | ||
| 2019-01-04 | Pedro Alvaro Amorrortu | Chief Operating Officer | Sell | 9,000.00 | 30.07 | 270,619.20 | 158,046.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000739/0000899243-19-000739-index.htm |
| 2020-07-28 | LYNETTE HERSCHA | Chief Legal Officer | Sell | 5,141.00 | 2.42 | 12,437.62 | 160,859.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm |
| 2020-07-27 | LYNETTE HERSCHA | Chief Legal Officer | Buy | 16,000.00 | 166,000.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043952/0001209191-20-043952-index.htm | ||
| 2018-12-03 | Pedro Alvaro Amorrortu | Chief Operating Officer | Sell | 300.00 | 32.38 | 9,714.99 | 167,046.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm |
| 2018-12-03 | Pedro Alvaro Amorrortu | Chief Operating Officer | Sell | 5,693.00 | 31.44 | 178,996.46 | 167,346.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm |
| 2018-12-03 | Pedro Alvaro Amorrortu | Chief Operating Officer | Sell | 3,007.00 | 30.20 | 90,822.83 | 173,039.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030088/0000899243-18-030088-index.htm |
| 2020-03-11 | Joel Solomon Zev Schneider | Chief Technology Officer | Buy | 75,000.00 | 201,656.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018918/0001209191-20-018918-index.htm | ||
| 2020-03-11 | Carl Ashley Morris | Chief Scientific Officer | Buy | 75,000.00 | 208,050.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018909/0001209191-20-018909-index.htm | ||
| 2018-12-03 | Jorge Armando Quiroz | Chief Medical Officer | Sell | 1,370.00 | 32.24 | 44,174.42 | 228,092.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm |
| 2018-12-03 | Jorge Armando Quiroz | Chief Medical Officer | Sell | 31,426.00 | 31.41 | 987,147.23 | 229,462.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm |
| 2020-02-10 | Ilan Ganot | CEO & President | Buy | 2,430.00 | 2,430.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120008912/0001209191-20-008912-index.htm | ||
| 2020-03-11 | Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | Buy | 75,000.00 | 244,700.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018892/0001209191-20-018892-index.htm | ||
| 2018-12-03 | Jorge Armando Quiroz | Chief Medical Officer | Sell | 6,154.00 | 30.21 | 185,900.03 | 260,888.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm |
| 2018-12-03 | Jorge Armando Quiroz | Chief Medical Officer | Sell | 1,200.00 | 29.94 | 35,923.68 | 267,042.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924318030087/0000899243-18-030087-index.htm |
| 2020-06-16 | Joel Solomon Zev Schneider | Chief Technology Officer | Buy | 75,000.00 | 276,656.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037696/0001209191-20-037696-index.htm | ||
| 2020-06-16 | Carl Ashley Morris | Chief Scientific Officer | Buy | 75,000.00 | 283,050.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037691/0001209191-20-037691-index.htm | ||
| 2020-07-28 | Joel Solomon Zev Schneider | Chief Technology Officer | Sell | 4,041.00 | 2.42 | 9,775.58 | 284,115.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm |
| 2020-07-27 | Joel Solomon Zev Schneider | Chief Technology Officer | Buy | 11,500.00 | 288,156.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043981/0001209191-20-043981-index.htm | ||
| 2020-07-28 | Carl Ashley Morris | Chief Scientific Officer | Sell | 3,591.00 | 2.42 | 8,689.14 | 290,959.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm |
| 2020-07-27 | Carl Ashley Morris | Chief Scientific Officer | Buy | 11,500.00 | 294,550.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043961/0001209191-20-043961-index.htm | ||
| 2020-06-16 | Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | Buy | 75,000.00 | 319,700.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120037698/0001209191-20-037698-index.htm | ||
| 2020-02-12 | Ilan Ganot | CEO & President | Buy | 800.00 | 3,230.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120009823/0001209191-20-009823-index.htm | ||
| 2020-07-28 | Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | Sell | 3,591.00 | 2.42 | 8,686.99 | 327,609.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm |
| 2020-07-27 | Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | Buy | 11,500.00 | 331,200.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120043957/0001209191-20-043957-index.htm | ||
| 2019-01-14 | Matthew Bennett Arnold | Director | Sell | 3,300.00 | 32.20 | 106,258.02 | 3,386,293.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm |
| 2019-01-14 | Matthew Bennett Arnold | Director | Sell | 1,700.00 | 31.60 | 53,723.74 | 3,389,593.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/0000899243-19-001270-index.htm |
| 2019-01-07 | Matthew Bennett Arnold | Director | Sell | 5,000.00 | 30.08 | 150,406.50 | 3,391,293.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319000742/0000899243-19-000742-index.htm |
| 2019-07-25 | Sukumar Nagendran | Director | Buy | 32,258.00 | 4.65 | 149,999.70 | 34,258.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043487/0001209191-19-043487-index.htm |
| 2019-03-28 | Boxer Capital, LLC | 10% Share Holder | Sell | 60,000.00 | 9.53 | 571,800.00 | 3,473,272.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm |
| 2020-08-13 | Ilan Ganot | CEO & President | Sell | 299.00 | 2.44 | 729.83 | 3,483.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm |
| 2019-07-25 | Matthew Bennett Arnold | Director | Buy | 677,419.00 | 4.65 | 3,149,998.35 | 3,500,997.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043479/0001209191-19-043479-index.htm |
| 2019-03-27 | Boxer Capital, LLC | 10% Share Holder | Sell | 115,000.00 | 9.60 | 1,104,000.00 | 3,533,272.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm |
| 2019-03-26 | Boxer Capital, LLC | 10% Share Holder | Sell | 275,000.00 | 10.08 | 2,772,000.00 | 3,648,272.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319009195/0000899243-19-009195-index.htm |
| 2020-08-12 | Ilan Ganot | CEO & President | Buy | 800.00 | 3,737.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120046769/0001209191-20-046769-index.htm | ||
| 2019-07-30 | Adam Koppel | Director | Buy | 1,881,720.00 | 4.65 | 8,749,998.00 | 3,871,164.00 | https://www.sec.gov/Archives/edgar/data/1707502/000089924319020588/0000899243-19-020588-index.htm |
| 2019-07-25 | Rajeev M. Shah | Director | Buy | 1,881,720.00 | 4.65 | 8,749,998.00 | 4,571,164.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043491/0001209191-19-043491-index.htm |
| 2019-07-25 | Martin I Freed | Director | Buy | 53,763.00 | 4.65 | 249,997.95 | 53,763.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919119043481/0001209191-19-043481-index.htm |
| 2019-07-25 | PERCEPTIVE ADVISORS LLC | Director | Buy | 2,822,581.00 | 4.65 | 13,125,001.65 | 6,749,803.00 | https://www.sec.gov/Archives/edgar/data/1707502/000101297519000502/0001012975-19-000502-index.htm |
| 2020-03-11 | LYNETTE HERSCHA | Chief Legal Officer | Buy | 75,000.00 | 75,000.00 | https://www.sec.gov/Archives/edgar/data/1707502/000120919120018883/0001209191-20-018883-index.htm |